Press Releases
Provepharm obtains European marketing authorization for its Methylthioninium Chloride...
Provepharm, a biotech start-up specialized in the development of pharmaceutical applications, announces today that it has just received official marketing authorization for its Methylthioninium Chloride...
Press Releases
Sagent Pharmaceuticals Plans Launch of Piperacillin and Tazobactam, the...
Sagent Pharmaceuticals, Inc. announced its planned launch of piperacillin and tazobactam for injection, the generic form of Zosyn®, in three distinct single dose vial forms....
Press Releases
Kodak Supports the Fight Against Counterfeit Pharmaceuticals
KODAK’s Security Solutions Group will attend the IQPC Anti-Counterfeiting for Pharma & Medical Devices seminar at The Chemical Heritage Foundation Conference Center in Philadelphia, Pa.,...
Press Releases
Cytheris and CITN announce selection of recombinant interleukin-7 (CYT107)...
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, and the Cancer Immunotherapy Trials Network (CITN),...
Press Releases
Roche and Merck Establish Strategic Agreements in Fight Against...
Roche announced that it has entered into agreements with Merck, known as MSD outside the United States, through their respective subsidiaries, to improve the treatment,...
Press Releases
FDA approves linagliptin tablets for the treatment of type...
Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along...
Press Releases
The European Commission Approves Pfizer’s Revatio for the Treatment...
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17 years...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.